Real-time enrollment status for this menstrual migraine clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06417775 |
| Recruiting Status | Recruiting |
| Condition | Menstrual Migraine |
| Phase | Clinical Trial |
| Target Enrollment | 450 participants |
| Active Locations | 96 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | November 12, 2025 (Nov 12, 2025) |
As of March 2, 2026: Clinical trial NCT06417775 is currently recruiting participants. This clinical trial study for menstrual migraine is actively seeking new participants at 96 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06417775 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 96 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06417775 was last updated Nov 12, 2025 (November 12, 2025). HelloStudys verifies this status automatically.